Wikidata

(Q40335527)

English

The proteasome inhibitor bortezomib (Velcade) sensitizes some human tumor cells to Apo2L/TRAIL-mediated apoptosis

scientific article published on November 2005

In more languages

Statements

title
The proteasome inhibitor bortezomib (Velcade) sensitizes some human tumor cells to Apo2L/TRAIL-mediated apoptosis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16382051
retrieved
19 September 2017
author name string
Alan D Brooks
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16382051
retrieved
19 September 2017
Teresa Ramirez
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
16382051
retrieved
19 September 2017
Uhi Toh
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
16382051
retrieved
19 September 2017
Jennifer Onksen
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
16382051
retrieved
19 September 2017
Peter J Elliott
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
16382051
retrieved
19 September 2017
Thomas J Sayers
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
16382051
retrieved
19 September 2017
William J Murphy
series ordinal
6
0 references
publication date
1 November 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
16382051
retrieved
19 September 2017
volume
1059
1 reference
stated in
Europe PubMed Central
PubMed ID
16382051
retrieved
19 September 2017
page(s)
160-167
1 reference
stated in
Europe PubMed Central
PubMed ID
16382051
retrieved
19 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40335527&oldid=1895558484"